{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:59:27Z","timestamp":1789610367616,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011941","name":"Gobierno del Principado de Asturias","doi-asserted-by":"publisher","award":["ACB-17-38"],"award-info":[{"award-number":["ACB-17-38"]}],"id":[{"id":"10.13039\/100011941","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Animal Research Tomorrow (Basel Declaration Society, CH-4000, Basel, Switzerland) - 3R's Award"},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-111418RB-100"],"award-info":[{"award-number":["PID2019-111418RB-100"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-111418RB-100"],"award-info":[{"award-number":["PID2019-111418RB-100"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Society for Free Radical Research-Europe (SFRR-E) - ECR Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Thioredoxin-Interacting Protein (TXNIP) is an arrestin at the crossroad of redox and glycolytic metabolisms. Prostate cancer (PCa) exhibits a unique metabolic profile due to the glycolytic nature of healthy prostate tissue. We hypothesize that TXNIP plays a pivotal role in the progression of PCa to castration-resistant prostate cancer (CRPC), an incurable stage of the disease characterized by profound metabolic reprogramming and independence from androgens. Only a subset of patients progresses to CRPC, and current stratification tools lack robust biomarkers. TXNIP expression is directly suppressed by androgens and diminishes during tumor initiation and progression, as demonstrated in both human samples and a prostate adenocarcinoma mouse model (TRAMP). TXNIP regulates glucose metabolism by sequestering the glucose transporter GLUT1 away from the membrane, shifting metabolism from glycolysis to glutaminolysis. Nuclear-localized TXNIP induces cell cycle arrest through the upregulation of p27\n                    <jats:sup>kip1<\/jats:sup>\n                    which is downregulated together with TXNIP in CRPC. The response to androgen deprivation therapy (ADT) strongly depends on TXNIP expression. In the murine model, TXNIP levels were significantly higher in ADT responders compared to non-responders. Furthermore, TRAMP-\n                    <jats:italic>Txnip<\/jats:italic>\n                    <jats:sup>\n                      <jats:bold>\u2212<\/jats:bold>\n                      \/\n                      <jats:bold>\u2212<\/jats:bold>\n                    <\/jats:sup>\n                    prostate tumors exhibited a poorer response to ADT, with increased Ki67 and enhanced viability. In clinical samples, all patients on relapse showed low levels of TXNIP and progressed to CRPC. Our findings identify TXNIP as a critical regulator of cell cycle and glucose metabolism in PCa and emphasize for the first time its essential role in mediating therapeutic responses to ADT.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08128-4","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:10:29Z","timestamp":1762787429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TXNIP upregulation controls metabolism and cell cycle during androgen deprivation therapy in prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7738-567X","authenticated-orcid":false,"given":"Sergio","family":"Alcon-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Gonzalez-Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3141-6493","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Fernandez-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hevia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Fernandez-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Moran-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1830-3056","authenticated-orcid":false,"given":"Daniela","family":"Pineda-Cevallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alvarez-Mugica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rodriguez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Garcia-Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M. C.","family":"Tubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3048-5582","authenticated-orcid":false,"given":"Rosa M.","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8101-8023","authenticated-orcid":false,"given":"Isabel","family":"Quiros-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"8128_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fonc.2017.00131","volume":"7","author":"E Eidelman","year":"2017","unstructured":"Eidelman E, Twum-Ampofo J, Ansari J, Siddiqui MM. The metabolic phenotype of prostate cancer. Front Oncol. 2017;7:131.","journal-title":"Front Oncol"},{"key":"8128_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8128_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. Prostate cancer. Nat Rev Dis Prim. 2021;7:1\u201327.","journal-title":"Nat Rev Dis Prim"},{"key":"8128_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","volume":"65","author":"M Kirby","year":"2011","unstructured":"Kirby M, Hirst C, Crawford ED. Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract. 2011;65:1180\u201392.","journal-title":"Int J Clin Pract"},{"key":"8128_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41391-020-0202-x","volume":"23","author":"S Meziou","year":"2020","unstructured":"Meziou S, Ringuette Goulet C, Hovington H, Lefebvre V, Lavall\u00e9e \u00c9, Bergeron M, et al. GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET\/CT and clinical outcome. Prostate Cancer Prostatic Dis. 2020;23:441\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"8128_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-022-00229-6","volume":"8","author":"A Bukkuri","year":"2022","unstructured":"Bukkuri A, Gatenby RA, Brown JS. GLUT1 production in cancer cells: a tragedy of the commons. npj Syst Biol Appl. 2022;8:22.","journal-title":"npj Syst Biol Appl"},{"key":"8128_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.redox.2018.03.017","volume":"17","author":"P Gonzalez-Menendez","year":"2018","unstructured":"Gonzalez-Menendez P, Hevia D, Alonso-Arias R, Alvarez-Artime A, Rodriguez-Garcia A, Kinet S, et al. GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress. Redox Biol. 2018;17:112\u201327.","journal-title":"Redox Biol"},{"key":"8128_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.canlet.2020.05.007","volume":"485","author":"J Wang","year":"2020","unstructured":"Wang J, Xu W, Wang B, Lin G, Wei Y, Abudurexiti M, et al. GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers. Cancer Lett. 2020;485:45\u201355.","journal-title":"Cancer Lett"},{"key":"8128_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.molcel.2013.01.035","volume":"49","author":"N Wu","year":"2013","unstructured":"Wu N, Zheng B, Shaywitz A, Dagon Y, Tower C, Bellinger G, et al. AMPK-dependent degradation of txnip upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell. 2013;49:1167\u201375.","journal-title":"Mol Cell"},{"key":"8128_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3958","volume":"5","author":"J Hwang","year":"2014","unstructured":"Hwang J, Suh HW, Jeon YHO, Hwang E, Nguyen LT, Yeom J, et al. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Nat Commun. 2014;5:2958.","journal-title":"Nat Commun"},{"key":"8128_CR11","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1074\/jbc.M109.034421","volume":"285","author":"G Saxena","year":"2010","unstructured":"Saxena G, Chen J, Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin- interacting protein. J Biol Chem. 2010;285:3997\u20134005.","journal-title":"J Biol Chem"},{"key":"8128_CR12","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1210\/en.2002-220564","volume":"143","author":"A Shalev","year":"2002","unstructured":"Shalev A, Pise-Masison CA, Radonovich M, Hoffmann SC, Hirshberg B, Brady JN, et al. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGF\u03b2 signaling pathway. Endocrinology. 2002;143:3695\u20138.","journal-title":"Endocrinology"},{"key":"8128_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.freeradbiomed.2010.10.715","volume":"50","author":"I Quiros-Gonzalez","year":"2011","unstructured":"Quiros-Gonzalez I, Sainz RM, Hevia D, Mayo JC. MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells. Free Radic Biol Med. 2011;50:525\u201336.","journal-title":"Free Radic Biol Med"},{"key":"8128_CR14","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1158\/0008-5472.CAN-04-2271","volume":"65","author":"JH Jeon","year":"2005","unstructured":"Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I. Tumor suppressor VDUP1 increases p27kip1 stability by inhibiting JAB1. Cancer Res. 2005;65:4485\u20139.","journal-title":"Cancer Res"},{"key":"8128_CR15","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.3390\/cells11203260","volume":"11","author":"K Nagaraj","year":"2022","unstructured":"Nagaraj K, Sarfstein R, Laron Z, Werner H. Long-term IGF1 stimulation leads to cellular senescence via functional interaction with the thioredoxin-interacting protein, TXNIP. Cells. 2022;11:3260.","journal-title":"Cells"},{"key":"8128_CR16","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/ijms22052754","volume":"22","author":"N Qayyum","year":"2021","unstructured":"Qayyum N, Haseeb M, Kim MS, Choi S. Role of thioredoxin-interacting protein in diseases and its therapeutic outlook. International J Mol Sci. 2021;22:2754.","journal-title":"International J Mol Sci"},{"key":"8128_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-022-02639-2","volume":"22","author":"X Guo","year":"2022","unstructured":"Guo X, Huang M, Zhang H, Chen Q, Hu Y, Meng Y, et al. A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker. Cancer Cell Int. 2022;22:1\u201316.","journal-title":"Cancer Cell Int"},{"key":"8128_CR18","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","volume":"92","author":"NM Greenberg","year":"1995","unstructured":"Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA. 1995;92:3439\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8128_CR19","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1161\/CIRCRESAHA.106.160515","volume":"101","author":"J Yoshioka","year":"2007","unstructured":"Yoshioka J, Imahashi K, Gabel SA, Chutkow WA, Burds AA, Gannon J, et al. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload. Circ Res. 2007;101:1328\u201338.","journal-title":"Circ Res"},{"key":"8128_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.aca.2017.03.019","volume":"969","author":"M Fern\u00e1ndez-Fern\u00e1ndez","year":"2017","unstructured":"Fern\u00e1ndez-Fern\u00e1ndez M, Rodr\u00edguez-Gonz\u00e1lez P, Hevia S\u00e1nchez D, Gonz\u00e1lez-Men\u00e9ndez P, Sainz Men\u00e9ndez RM, Garc\u00eda Alonso JI. Accurate and sensitive determination of molar fractions of (13)C-Labeled intracellular metabolites in cell cultures grown in the presence of isotopically-labeled glucose. Analytica Chim acta. 2017;969:35\u201348.","journal-title":"Analytica Chim acta"},{"key":"8128_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2021.339043","volume":"1210","author":"F Rey-Stolle","year":"2022","unstructured":"Rey-Stolle F, Dudzik D, Gonzalez-Riano C, Fern\u00e1ndez-Garc\u00eda M, Alonso-Herranz V, Rojo D, et al. Low and high resolution gas chromatography-mass spectrometry for untargeted metabolomics: a tutorial. Analytica Chim acta. 2022;1210:339043.","journal-title":"Analytica Chim acta"},{"key":"8128_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52:398\u2013406.","journal-title":"Nucleic Acids Res"},{"key":"8128_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y, et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat Protoc. 2016;11:347\u201358.","journal-title":"Nat Protoc"},{"key":"8128_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Scientific Rep. 2017;7:16878.","journal-title":"Scientific Rep"},{"key":"8128_CR25","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1158\/0008-5472.CAN-05-3055","volume":"66","author":"P Liu","year":"2006","unstructured":"Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, et al. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 2006;66:4011\u20139.","journal-title":"Cancer Res"},{"key":"8128_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep16018","volume":"5","author":"MM Mortensen","year":"2015","unstructured":"Mortensen MM, H\u00f8yer S, Lynnerup A-S, \u00d8rntoft TF, S\u00f8rensen KD, Borre M, et al. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Scientific Rep. 2015;5:16018.","journal-title":"Scientific Rep"},{"key":"8128_CR27","doi-asserted-by":"publisher","first-page":"114845","DOI":"10.18632\/oncotarget.22296","volume":"8","author":"SJ Yun","year":"2017","unstructured":"Yun SJ, Kim S-K, Kim J, Cha E-J, Kim J-S, Kim S-J, et al. Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer. Oncotarget. 2017;8:114845\u201355.","journal-title":"Oncotarget"},{"key":"8128_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso CS, Wu Y-M, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487:239\u201343.","journal-title":"Nature"},{"key":"8128_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/jcb.25054","volume":"116","author":"N Harada","year":"2015","unstructured":"Harada N, Katsuki T, Takahashi Y, Masuda T, Yoshinaga M, Adachi T, et al. Androgen receptor silences thioredoxin-interacting protein and competitively inhibits glucocorticoid receptor-mediated apoptosis in pancreatic \u03b2-cells. J Cell Biochem. 2015;116:998\u20131006.","journal-title":"J Cell Biochem"},{"key":"8128_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","volume":"18","author":"X Messeguer","year":"2002","unstructured":"Messeguer X, Escudero R, Farr\u00e9 D, N\u00fa\u00f1ez O, Mart\u00ednez J, Alb\u00e0 MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18:333\u20134.","journal-title":"Bioinformatics"},{"key":"8128_CR31","doi-asserted-by":"publisher","first-page":"37559","DOI":"10.1074\/jbc.M405473200","volume":"279","author":"Y Nishinaka","year":"2004","unstructured":"Nishinaka Y, Masutani H, Oka S, Matsuo Y, Yamaguchi Y, Nishio K, et al. Importin 1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2\/Vitamin D 3-up-regulated Protein 1. J Biol Chem. 2004;279:37559\u201365.","journal-title":"J Biol Chem"},{"key":"8128_CR32","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1210\/en.2005-1001","volume":"147","author":"JA Magee","year":"2006","unstructured":"Magee JA, Chang LW, Stormo GD, Milbrandt J. Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology. 2006;147:590\u20138.","journal-title":"Endocrinology"},{"key":"8128_CR33","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217209","volume":"15","author":"J Terzic","year":"2023","unstructured":"Terzic J, Abu El Maaty MA, Lutzing R, Vincent A, El Bizri R, Jung M, et al. Hypoxia-inducible factor 1A inhibition overcomes castration resistance of prostate tumors. EMBO Mol Med. 2023;15:e17209.","journal-title":"EMBO Mol Med"},{"key":"8128_CR34","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41556-023-01274-x","volume":"25","author":"JM Giafaglione","year":"2023","unstructured":"Giafaglione JM, Crowell PD, Delcourt AML, Hashimoto T, Ha SM, Atmakuri A, et al. Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. Nat Cell Biol. 2023;25:1821\u201332.","journal-title":"Nat Cell Biol"},{"key":"8128_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/cancers14030749","volume":"14","author":"M Marhold","year":"2022","unstructured":"Marhold M, Udovica S, Topakian T, Horak P, Horvat R, Tomasich E, et al. MALAT1 fusions and basal cells contribute to primary resistance against androgen receptor inhibition in TRAMP Mice. Cancers. 2022;14:749.","journal-title":"Cancers"},{"key":"8128_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10798","volume":"7","author":"D Zhang","year":"2016","unstructured":"Zhang D, Park D, Zhong Y, Lu Y, Rycaj K, Gong S, et al. Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer. Nat Commun. 2016;7:10798.","journal-title":"Nat Commun"},{"key":"8128_CR37","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.celrep.2019.07.007","volume":"28","author":"PD Crowell","year":"2019","unstructured":"Crowell PD, Fox JJ, Hashimoto T, Diaz JA, Navarro HI, Henry GH, et al. Expansion of luminal progenitor cells in the aging mouse and human prostate. Cell Rep. 2019;28:1499\u20131510.e6.","journal-title":"Cell Rep"},{"key":"8128_CR38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbrc.2018.03.020","volume":"498","author":"JW Park","year":"2018","unstructured":"Park JW, Lee SH, Woo GH, Kwon HJ, Kim DY. Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer. Biochem Biophys Res Commun. 2018;498:566\u201372.","journal-title":"Biochem Biophys Res Commun"},{"key":"8128_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101838","volume":"39","author":"J Jandova","year":"2021","unstructured":"Jandova J, Wondrak GT. Genomic GLO1 deletion modulates TXNIP expression, glucose metabolism, and redox homeostasis while accelerating human A375 malignant melanoma tumor growth. Redox Biol. 2021;39:101838.","journal-title":"Redox Biol"},{"key":"8128_CR40","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.3390\/ijms23147743","volume":"23","author":"KH Park","year":"2022","unstructured":"Park KH, Yang J-W, Kwon J-H, Lee H, Yoon YD, Choi BJ, et al. Targeted induction of endogenous VDUP1 by small activating RNA inhibits the growth of lung cancer cells. Int J Mol Sci. 2022;23:7743.","journal-title":"Int J Mol Sci"},{"key":"8128_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96220-y","volume":"11","author":"M Meszaros","year":"2021","unstructured":"Meszaros M, Yusenko M, Domonkos L, Peterfi L, Kovacs G, Banyai D. Expression of TXNIP is associated with angiogenesis and postoperative relapse of conventional renal cell carcinoma. Sci Rep. 2021;11:17200.","journal-title":"Sci Rep"},{"key":"8128_CR42","doi-asserted-by":"publisher","first-page":"36849","DOI":"10.18632\/oncotarget.26402","volume":"9","author":"A Gunes","year":"2018","unstructured":"Gunes A, Bagirsakci E, Iscan E, Cakan-Akdogan G, Aykutlu U, Senturk S, et al. Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma. Oncotarget. 2018;9:36849\u201366.","journal-title":"Oncotarget"},{"key":"8128_CR43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.canlet.2017.06.031","volume":"403","author":"D Bencivenga","year":"2017","unstructured":"Bencivenga D, Caldarelli I, Stampone E, Mancini FP, Balestrieri ML, Della Ragione F, et al. p27Kip1 and human cancers: a reappraisal of a still enigmatic protein. Cancer Lett. 2017;403:354\u201365.","journal-title":"Cancer Lett"},{"key":"8128_CR44","first-page":"542","volume":"58","author":"J Tsihlias","year":"1998","unstructured":"Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, et al. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res. 1998;58:542\u20138.","journal-title":"Cancer Res"},{"key":"8128_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1263\/jbb.106.248","volume":"106","author":"F Yamaguchi","year":"2008","unstructured":"Yamaguchi F, Kamitori K, Sanada K, Horii M, Dong Y, Sui L, et al. Rare sugar d-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7. J Biosci Bioeng. 2008;106:248\u201352.","journal-title":"J Biosci Bioeng"},{"key":"8128_CR46","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/cbin.11418","volume":"44","author":"M Xie","year":"2020","unstructured":"Xie M, Xie R, Xie S, Wu Y, Wang W, Li X, et al. Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer. Cell Biol Int. 2020;44:2094\u2013106.","journal-title":"Cell Biol Int"},{"key":"8128_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01462-0","volume":"22","author":"G Ambrosini","year":"2024","unstructured":"Ambrosini G, Cordani M, Zarrabi A, Alcon-Rodriguez S, Sainz RM, Velasco G, et al. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies. Cell Commun Signal. 2024;22:36.","journal-title":"Cell Commun Signal"},{"key":"8128_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101926","volume":"45","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Yang W, Wu W, Jin F, Lu D, Gao J, et al. Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics. Translational Oncol. 2024;45:101926.","journal-title":"Translational Oncol"},{"key":"8128_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106915","volume":"196","author":"W Bao","year":"2023","unstructured":"Bao W, Wang J, Fan K, Gao Y, Chen J. PIAS3 promotes ferroptosis by regulating TXNIP via TGF-\u03b2 signaling pathway in hepatocellular carcinoma. Pharmacol Res. 2023;196:106915.","journal-title":"Pharmacol Res"},{"key":"8128_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/metabo13030345","volume":"13","author":"MK Ediriweera","year":"2023","unstructured":"Ediriweera MK, Jayasena S. The role of reprogrammed glucose metabolism in cancer. Metabolites. 2023;13:345.","journal-title":"Metabolites"},{"key":"8128_CR51","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, Byun J-K, Choi Y-K, Park K-G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55:706\u201315.","journal-title":"Exp Mol Med"},{"key":"8128_CR52","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","volume":"125","author":"F Ahmad","year":"2021","unstructured":"Ahmad F, Cherukuri MK, Choyke PL. Metabolic reprogramming in prostate cancer. Br J Cancer. 2021;125:1185\u201396.","journal-title":"Br J Cancer"},{"key":"8128_CR53","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1073\/pnas.1501555112","volume":"112","author":"L Shen","year":"2015","unstructured":"Shen L, O\u2019Shea JM, Kaadige MR, Cunha S, Wilde BR, Cohen AL, et al. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP. Proc Natl Acad Sci USA. 2015;112:5425\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8128_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05811-2","volume":"14","author":"L Feng","year":"2023","unstructured":"Feng L, Ding R, Qu X, Li Y, Shen T, Wang L, et al. BCR-ABL triggers a glucose-dependent survival program during leukemogenesis through the suppression of TXNIP. Cell Death Dis. 2023;14:1\u201314.","journal-title":"Cell Death Dis"},{"key":"8128_CR55","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-23-0519","volume":"84","author":"N Boufaied","year":"2024","unstructured":"Boufaied N, Chetta P, Hallal T, Cacciatore S, Lalli D, Luthold C, et al. Obesogenic high-fat diet and myc cooperate to promote lactate accumulation and tumor microenvironment remodeling in prostate cancer. Cancer Res. 2024;84:1834\u201355.","journal-title":"Cancer Res"},{"key":"8128_CR56","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/bjc.2016.37","volume":"114","author":"C Garc\u00eda-Jim\u00e9nez","year":"2016","unstructured":"Garc\u00eda-Jim\u00e9nez C, Guti\u00e9rrez-Salmer\u00f3n M, Chocarro-Calvo A, Garc\u00eda-Martinez JM, Casta\u00f1o A, De la Vieja A. From obesity to diabetes and cancer: epidemiological links and role of therapies. Br J Cancer. 2016;114:716\u201322.","journal-title":"Br J Cancer"},{"key":"8128_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1476444","volume":"15","author":"G Jing","year":"2024","unstructured":"Jing G, Jo S, Shalev A. A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging. Front Endocrinol. 2024;15:1476444.","journal-title":"Front Endocrinol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08128-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08128-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08128-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T16:03:30Z","timestamp":1762790610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08128-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8128"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08128-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All studies involving human samples were conducted in accordance with the Declaration of Helsinki, with approval from the Ethics Research Committee of Principado de Asturias (CEImPA, project code 2022.073). Written informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"817"}}